Dario Amodei, Chief Scientist and CEO of Anthropic, has written another important article you should read: The Urgency of ...

Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M ...

The company plans to deepen its dataset, expand collaborations in oncology, autoimmune, and cardiovascular research, and ...

Dario Amodei predicts the “MRI for AI” will be here in five to 10 years. And, he outlines three ways to achieve AI model interpretability sooner.

Looking for a "Good Hang" with Silicon Valley’s top thinkers, makers, and doers? INBOUND 2025 has you covered. For the first ...

AI has made immense strides since then, but many of us are—and let me put this delicately—too unsophisticated to notice. Max ...

Anthropic’s answer? A moonshot goal to develop what Amodei calls an “MRI for AI”—a rigorous, high-resolution way to peer ...

Anthropic CEO Dario Amodei set forth a goal for his company to "reliably detect most AI model problems" by 2027.

Biostate AI, a molecular diagnostics startup combining next-generation RNA sequencing (RNAseq) with generative AI, announced ...

Join this free virtual event, featuring Ali Ghodsi, the trailblazing co-founder and CEO of Databricks, alongside Dario Amodei, the pioneering co-founder and CEO of Anthropic. Uncover how their ...